These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11430504)

  • 1. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing gastro-oesophageal reflux disease in primary care.
    Nathoo V
    Int J Clin Pract; 2001 Sep; 55(7):465-9. PubMed ID: 11594257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortcomings of the first-generation proton pump inhibitors.
    Tytgat GN
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S29-33. PubMed ID: 11430506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease.
    Jenkinson AD; Kadirkamanathan SS; Scott SM; Yazaki E; Evans DF
    Br J Surg; 2004 Nov; 91(11):1460-5. PubMed ID: 15386326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease.
    Savarino V; Dulbecco P
    Digestion; 2004; 69 Suppl 1():9-16. PubMed ID: 15001830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors in the elderly population.
    Whitaker M
    Eur J Gastroenterol Hepatol; 2002 Sep; 14 Suppl 1():S5-9. PubMed ID: 12570023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving on PPI-based therapy of GORD.
    Sachs G
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S35-41. PubMed ID: 11430507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
    Lundell L
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.